Source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=814&amp;showFR=1&amp;subpartNode=21:8.0.1.1.11.7
Timestamp: 2019-04-20 14:37:04+00:00

Document:
§ 814.9 - Confidentiality of data and information in a premarket approval application (PMA) file.
§ 814.15 - Research conducted outside the United States.
§ 814.17 - Service of orders.
§ 814.19 - Product development protocol (PDP).
§ 814.37 - PMA amendments and resubmitted PMAs.
§ 814.39 - PMA supplements.
§ 814.40 - Time frames for reviewing a PMA.
§ 814.42 - Filing a PMA.
§ 814.44 - Procedures for review of a PMA.
§ 814.45 - Denial of approval of a PMA.
§ 814.46 - Withdrawal of approval of a PMA.
§ 814.47 - Temporary suspension of approval of a PMA.
§ 814.82 - Postapproval requirements.
§ 814.100 - Purpose and scope.
§ 814.102 - Designation of HUD status.
§ 814.104 - Original applications.
§ 814.106 - HDE amendments and resubmitted HDE's.
§ 814.108 - Supplemental applications.
§ 814.110 - New indications for use.
§ 814.112 - Filing an HDE.
§ 814.114 - Timeframes for reviewing an HDE.
§ 814.116 - Procedures for review of an HDE.
§ 814.118 - Denial of approval or withdrawal of approval of an HDE.
§ 814.120 - Temporary suspension of approval of an HDE.
§ 814.122 - Confidentiality of data and information.
§ 814.124 - Institutional Review Board requirements.
§ 814.126 - Postapproval requirements and reports.
Authority: 21 U.S.C. 351, 352, 353, 360, 360c-360j, 360bbb-8b, 371, 372, 373, 374, 375, 379, 379e, 381.
Source: 51 FR 26364, July 22, 1986, unless otherwise noted.

References: § 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814

§ 814